Research: Immunotherapy may hold hope for cancer treatment

Immunotherapy, using a patient's genetically altered T-cells as a cancer treatment, may hold promise for some. Recent research indicates that the expensive process can slow, halt or seemingly cure metastatic cancer in some patients. Using a BiTE antibody, created by Maryland-based Micromet, may hold even more promise for immunotherapy by attaching to both the cancer cell and the T-cell and telling the T-cell to attack. Seven patients who received the therapy have experienced either a complete or partial response.

View Full Article in:

Telegraph (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA